Compounds > gamma-glutamine-4-nitroanilide
Page last updated: 2024-08-25

gamma-glutamine-4-nitroanilide and Neoplasms

gamma-glutamine-4-nitroanilide has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, X; Bian, J; Dai, W; Li, L; Li, Z; Meng, Y; Xu, X1
Belcastro, E; Bussolati, O; Chiu, M; Corti, A; Dominici, S; Pacini, S; Piaggi, S; Pompella, A; Taurino, G1

Reviews

1 review(s) available for gamma-glutamine-4-nitroanilide and Neoplasms

ArticleYear
Discovery and development of small molecule modulators targeting glutamine metabolism.
    European journal of medicinal chemistry, 2019, Feb-01, Volume: 163

    Topics: Animals; Antineoplastic Agents; Drug Discovery; Energy Metabolism; Glutamine; Humans; Neoplasms

2019

Other Studies

1 other study(ies) available for gamma-glutamine-4-nitroanilide and Neoplasms

ArticleYear
γ-Glutamyltransferase enzyme activity of cancer cells modulates L-γ-glutamyl-p-nitroanilide (GPNA) cytotoxicity.
    Scientific reports, 2019, 01-29, Volume: 9, Issue:1

    Topics: Acetylcysteine; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Enzyme Activation; gamma-Glutamyltransferase; Glutamine; Humans; Hydrolysis; Metabolic Detoxication, Phase I; Neoplasms; Reactive Oxygen Species

2019